CLINICAL_TRIALS
research
· 2026-03-09
Clinical Trial Update: A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
Summary
This clinical trial investigates nusinersen (Spinraza) exposure before or during pregnancy in people with spinal muscular atrophy and assesses the health outcom…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: RECRUITING